Triggering of inflammatory response by myeloperoxidase-oxidized LDL.

The oxidation theory proposes that LDL oxidation is an early event in atherosclerosis and that oxidized LDL contributes to atherogenesis in triggering inflammation. In contrast to the copper-modified LDL, there are few studies using myeloperoxidase-modified LDL (Mox-LDL) as an inflammation inducer. Our aim is to test whether Mox-LDL could constitute a specific inducer of the inflammatory response. Albumin, which is the most abundant protein in plasma and which is present to an identical concentration of LDL in the intima, was used for comparison. The secretion of IL-8 by endothelial cells (Ea.hy926) and TNF-alpha by monocytes (THP-1) was measured in the cell medium after exposure of these cells to native LDL, native albumin, Mox-LDL, or Mox-albumin. We observed that Mox-LDL induced a 1.5- and 2-fold increase (ANOVA; P < 0.001) in IL-8 production at 100 microg/mL and 200 microg/mL, respectively. The incubation of THP-1 cells with Mox-LDL (100 microg/mL) increased the production of TNF-alpha 2-fold over the control. Native LDL, albumin, and Mox-albumin showed no effect in either cellular types. The myeloperoxidase-modified LDL increase in cytokine release by endothelial and monocyte cells and by firing both local and systemic inflammation could induce atherogenesis and its development.

[1]  C. Remacle,et al.  Oxidation of low density lipoproteins by myeloperoxidase at the surface of endothelial cells: an additional mechanism to subendothelium oxidation. , 2004, Biochemical and biophysical research communications.

[2]  J. Ordóñez‐Llanos,et al.  Increased lysophosphatidylcholine and non-esterified fatty acid content in LDL induces chemokine release in endothelial cells. Relationship with electronegative LDL. , 2004, Atherosclerosis.

[3]  P. Delrée,et al.  Monoclonal antibodies against LDL progressively oxidized by myeloperoxidase react with ApoB-100 protein moiety and human atherosclerotic lesions. , 2004, Biochemical and biophysical research communications.

[4]  J. Keaney,et al.  Role of oxidative modifications in atherosclerosis. , 2004, Physiological reviews.

[5]  W. März,et al.  Beyond cholesterol - inflammatory cytokines, the key mediators in atherosclerosis , 2004, Clinical chemistry and laboratory medicine.

[6]  G. Sonnenberg,et al.  A novel pathway to the manifestations of metabolic syndrome. , 2004, Obesity research.

[7]  Chunxiang Zhang,et al.  Interaction of myeloperoxidase with vascular NAD(P)H oxidase-derived reactive oxygen species in vasculature: implications for vascular diseases. , 2003, American journal of physiology. Heart and circulatory physiology.

[8]  E. Topol,et al.  Prognostic value of myeloperoxidase in patients with chest pain. , 2003, The New England journal of medicine.

[9]  C. Heeschen,et al.  Myeloperoxidase Serum Levels Predict Risk in Patients With Acute Coronary Syndromes , 2003, Circulation.

[10]  L. Lind.  Circulating markers of inflammation and atherosclerosis. , 2003, Atherosclerosis.

[11]  S. Hazen,et al.  Statins Promote Potent Systemic Antioxidant Effects Through Specific Inflammatory Pathways , 2003, Circulation.

[12]  J. Heinecke.  Oxidative stress: new approaches to diagnosis and prognosis in atherosclerosis. , 2003, The American journal of cardiology.

[13]  Prapat Suriyaphol,et al.  Enzymatically Modified Nonoxidized Low-Density Lipoprotein Induces Interleukin-8 in Human Endothelial Cells: Role of Free Fatty Acids , 2002, Circulation.

[14]  G. Hansson.  Regulation of Immune Mechanisms in Atherosclerosis , 2001, Annals of the New York Academy of Sciences.

[15]  E J Topol,et al.  Association between myeloperoxidase levels and risk of coronary artery disease. , 2001, JAMA.

[16]  R. Heller,et al.  Identification of the human analog of SR-BI and LOX-1 as receptors for hypochlorite-modified high density lipoprotein on human umbilical venous endothelial cells. , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  A. Carr,et al.  Myeloperoxidase binds to low‐density lipoprotein: potential implications for atherosclerosis , 2000, FEBS letters.

[18]  D. Kutter,et al.  Consequences of Total and Subtotal Myeloperoxidase Deficiency: Risk or Benefit ? , 2000, Acta Haematologica.

[19]  A. Pitt,et al.  Pathways of phospholipid oxidation by HOCl in human LDL detected by LC-MS. , 2000, Free radical biology & medicine.

[20]  F. Luscinskas,et al.  MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions , 1999, Nature.

[21]  R. Terkeltaub,et al.  Chemokines and atherosclerosis. , 1998, Current opinion in lipidology.

[22]  I. Erdelmeier,et al.  Reactions of 1-methyl-2-phenylindole with malondialdehyde and 4-hydroxyalkenals. Analytical applications to a colorimetric assay of lipid peroxidation. , 1998, Chemical research in toxicology.

[23]  J. Ando,et al.  Fluid shear stress transcriptionally induces lectin-like oxidized LDL receptor-1 in vascular endothelial cells. , 1998, Circulation research.

[24]  M. Hayn,et al.  Human low density lipoprotein as a target of hypochlorite generated by myeloperoxidase. , 1998, Free radical biology & medicine.

[25]  B. Kalyanaraman,et al.  The mechanism of apolipoprotein B-100 thiol depletion during oxidative modification of low-density lipoprotein. , 1997, Archives of biochemistry and biophysics.

[26]  L. Packer,et al.  Comparison between copper-mediated and hypochlorite-mediated modifications of human low density lipoproteins evaluated by protein carbonyl formation. , 1997, Journal of lipid research.

[27]  A. Abella,et al.  Oxidized low‐density lipoprotein induces the production of interleukin‐8 by endothelial cells , 1996, FEBS letters.

[28]  B. Nordestgaard,et al.  Oxidation of plasma low-density lipoprotein accelerates its accumulation and degradation in the arterial wall in vivo. , 1996, Circulation.

[29]  S. L. Hazen,et al.  Molecular Chlorine Generated by the Myeloperoxidase-Hydrogen Peroxide-Chloride System of Phagocytes Converts Low Density Lipoprotein Cholesterol into a Family of Chlorinated Sterols* , 1996, The Journal of Biological Chemistry.

[30]  J. Holland,et al.  Atherogenic levels of low‐density lipoprotein increase hydrogen peroxide generation in cultured human endothelial cells: Possible mechanism of heightened endocytosis , 1996, Journal of cellular physiology.

[31]  L. Packer,et al.  Spectrophotometric method for determination of carbonyls in oxidatively modified apolipoprotein B of human low-density lipoproteins. , 1995, Analytical biochemistry.

[32]  A. Daugherty,et al.  Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. , 1994, The Journal of clinical investigation.

[33]  J. Gauldie,et al.  The acute phase response. , 1994, Immunology today.

[34]  C. Edgell,et al.  Extent of Differentiated Gene Expression in the Human Endothelium-Derived EA.hy926 Cell Line , 1993, Thrombosis and Haemostasis.

[35]  H. Esterbauer,et al.  The role of lipid peroxidation and antioxidants in oxidative modification of LDL. , 1992, Free radical biology & medicine.

[36]  K. Feingold,et al.  Role of Cytokines in Inducing Hyperlipidemia , 1992, Diabetes.

[37]  F. Luscinskas,et al.  In vitro inhibitory effect of IL-8 and other chemoattractants on neutrophil-endothelial adhesive interactions. , 1992, Journal of immunology.

[38]  L. Fabry,et al.  Structural and biological properties of human recombinant myeloperoxidase produced by Chinese hamster ovary cell lines. , 1991, European journal of biochemistry.

[39]  J. Auwerx,et al.  The human leukemia cell line, THP-1: A multifacetted model for the study of monocyte-macrophage differentiation , 1991, Experientia.

[40]  C. R. Bagnell,et al.  Endothelium specific Weibel-Palade bodies in a continuous human cell line, EA.hy926 , 1990, In Vitro Cellular & Developmental Biology.

[41]  J. Freyssinet,et al.  Stability of the thrombin-thrombomodulin complex on the surface of endothelial cells from human saphenous vein or from the cell line EA.hy 926. , 1989, The Biochemical journal.

[42]  E. B. Smith,et al.  Distribution of plasma proteins across the human aortic wall--barrier functions of endothelium and internal elastic lamina. , 1980, Atherosclerosis.

[43]  Shigeru Tsuchiya,et al.  Establishment and characterization of a human acute monocytic leukemia cell line (THP‐1) , 1980, International journal of cancer.

[44]  J. Sznajd,et al.  Myeloperoxidase of Human Leukaemic Leucocytes , 1968 .

[45]  R. Havel,et al.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.

[46]  A. Szuba,et al.  The role of chemokines in human cardiovascular pathology: enhanced biological insights. , 2002, Atherosclerosis.

[47]  A. Pitt,et al.  The reactions of hypochlorous acid, the reactive oxygen species produced by myeloperoxidase, with lipids. , 2000, Acta biochimica Polonica.

[48]  D. Gemsa,et al.  Hypochlorite-modified LDL: chemotactic potential and chemokine induction in human monocytes. , 1998, Clinical immunology and immunopathology.

[49]  R. Terkeltaub,et al.  Oxidized LDL induces monocytic cell expression of interleukin-8, a chemokine with T-lymphocyte chemotactic activity. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[50]  B. Spiegelman,et al.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.